Most coronavirus-positive cancer patients are asymptomatic

Most studies have shown that many cancer patients are at high risk of developing severe forms of COVID-19. In a study of nearly 900 cancer patients with coronavirus in the UK, for instance, the death rate was estimated to be 33.6%, which is much higher than the general population. However, most of these patients were […]

read more

NHS England need for new diagnostic services

A report from NHS England has found that the COVID-19 pandemic has identified a need for a ‘radical change’ in diagnostic services across the country. This report was close to publication before the pandemic identified additional actions needed to deliver higher quality diagnostic services. As part of this ‘radical change’ NHS England identified a number […]

read more

Burnout among cancer professionals during COVID-19

Two online surveys presented at the European Society of Medical Oncology (ESMO) outlined the extent to which the COVID-19 pandemic has affected burnout, job performance, and wellbeing in the global oncology workforce. The first survey included 1520 people from 101 countries between 16 April and 3 May 2020. Of these, 38% stated that they had […]

read more

How the coronavirus pandemic may affect cancer clinical trials

In this article published in Cancer Therapy Advisor this week, changes to how clinical trials are being conducted due to the health risks posed by COVID-19 to cancer patients are discussed. Some of these changes include the use of telemedicine visits, electronic signatures for signing patient consent forms, posting oral medicines to patients’ homes, and […]

read more

Scotland’s plan to remobilise and redesign cancer services

The Government in Scotland has published a new plan to remobilise NHS cancer care to put the experience of patients at its heart. It will focus on improving services and ensuring that all patients have access to the best possible treatments. The coronavirus (COVID-19) pandemic has resulted in significant changes to the war cancer services […]

read more

Circulating tumour DNA as a potential prognostic biomarker for immunotherapy

A study published in Nature Cancer showed that blood levels of DNA from solid tumours (circulating tumour DNA or ctDNA) were associated with the prognosis of cancer patients with different types of  tumours who had been treated with pembrolizumab. The study included 94 patients with various solid tumours who were treated with pembrolizumab. ctDNA levels varied […]

read more

COVID-19 outcomes with anticancer treatments

There is a lot of ongoing research to understand the effect of cancer and its treatment on the outcomes of patients who contract COVID-19. Cancer patients could be at greater risk from COVID-19 because their immune systems are suppressed or they have other conditions due to their cancer or its treatment. Cancer patients are also […]

read more

Delay in cancer diagnosis during COVID-19 – what next?

This article in The Lancet describes the impact of the COVID-19 pandemic on the two-week wait referral for cancer diagnosis in the UK from the results of two modelling studies looking at up to 20 different cancers. The article concludes that patients whose symptoms indicate cancer have been disadvantaged, and some patients will die as […]

read more

Study shows steep rise in people waiting for cancer tests

The results from two studies have been released to show the impact of the COVID-19 pandemic on cancer care in the UK. Data from Cancer Research UK showed a steep rise in the number of people waiting for diagnostic tests, while a study by the Institute for Cancer Research (ICR) published in The Lancet warned that […]

read more
Showing 1 to 10 of 139 results
  TOP